首页> 中文期刊> 《中华消化外科杂志》 >获得性免疫耐受的机制与临床意义

获得性免疫耐受的机制与临床意义

摘要

The first unequivocally successful bone marrow cell transplantation in humans was recorded in 1968 by the Universitv of Minnesota team of Robert A.Good.This achievement was a direct extension of mouse models of acquired immunologic tolerance that were established 15 years earlier.In contrast,organ(i.e.kidney)transplantation was accomplished precociously in humans(in 1959)before demonstrating its feasibility in any experimental model and in the absence of a defensible immunologic rationale.Because of the striking differences between the outcomes with the 2 kinds of procedure,the mechanisms of organ engraftment were long thought to differ from the leukocyte ehimerism-associated ones of bone marrow transplantation.This and other concepts of alloengraftment and acquired tolerance have changed over time.Current concepts and their clinical implications can be understood and discussed best from the perspective provided by the life and times of Bob Good.

著录项

  • 来源
    《中华消化外科杂志》 |2008年第2期|83-85|共3页
  • 作者单位

    PA,15213,美国匹兹堡大学医学中心,Thomas E.Starzl移植研究所;

    400038,重庆,第三军医大学西南医院全军肝胆外科研究所、中国人民解放军西南肝胆外科医院;

    400038,重庆,第三军医大学西南医院全军肝胆外科研究所、中国人民解放军西南肝胆外科医院;

  • 原文格式 PDF
  • 正文语种 chi
  • 中图分类 肝及肝管;
  • 关键词

    获得性免疫耐受; 嵌合; 肝移植;

相似文献

  • 中文文献
  • 外文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号